See All Slides - tctmd.com

Slides

Presentation TCT 2013

Case Presentation Conclusion: Procedural and Patient Outcomes(4)

Presenter: Brian Clapp

October 30, 2013

Presentation TCT 2013

The Medical Device Innovation Consortium (MDIC): A Solution to the Clinical Study Landscape

Presenter: Michael Minogue

October 30, 2013

Presentation TCT 2013

Cath Lab Standardized EHR Reporting Overview

Presenter: Andrew Klein

October 30, 2013

Presentation TCT 2013

Dissecting the MitraClip Device: Clip Design and Function and the Delivery System

Presenter: Frederick St. Goar

October 30, 2013

Presentation TCT 2013

Optimized Medical Therapy for the PAD Patient, With or Without Intervention

Presenter: Michael Jaff

October 30, 2013

Presentation TCT 2013

Innovations in Advanced Heart Failure Therapies

Presenter: Daniel Burkhoff

October 30, 2013

Presentation TCT 2013

Real-Time Device Surveillance

Presenter: Mladen Vidovich

October 30, 2013

Presentation TCT 2013

TCT-126. First-in-human experience with a novel high-flow percutaneous heart pump

Presenter: David Kandzari

October 30, 2013

Presentation TCT 2013

When is a Second Stent Required (Planned and Provisional)

Presenter: Goran Stankovic

October 30, 2013

Presentation TCT 2013

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - For: The Data are Clear (And Common Sense Rules): TAVR is a Lower Risk Option than...

Presenter: Daniel Blackman

October 30, 2013

Advertisement

Slides

Case Presentation Conclusion: Procedural and Patient Outcomes(4)

The Medical Device Innovation Consortium (MDIC): A Solution to the Clinical Study Landscape

Cath Lab Standardized EHR Reporting Overview

Dissecting the MitraClip Device: Clip Design and Function and the Delivery System

Optimized Medical Therapy for the PAD Patient, With or Without Intervention

Innovations in Advanced Heart Failure Therapies

Real-Time Device Surveillance

TCT-126. First-in-human experience with a novel high-flow percutaneous heart pump

When is a Second Stent Required (Planned and Provisional)

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - For: The Data are Clear (And Common Sense Rules): TAVR is a Lower Risk Option than...

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content